# Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

> **NCT05756660** · EARLY_PHASE1 · SUSPENDED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 33 (estimated)

## Conditions studied

- Ototoxicity, Drug-Induced

## Interventions

- **DRUG:** Sodium Thiosulfate

## Key facts

- **NCT ID:** NCT05756660
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-03-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 33 (ESTIMATED)
- **Why stopped:** This study will be closing at CCHMC and may be transferred to a principal investigator at another insitutiton.
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05756660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05756660, "Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05756660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*